Formation of a Regulatory Factor X/X2 Box-Binding Protein/Nuclear Factor-Y Multiprotein Complex on the Conserved Regulatory Regions of HLA Class II Genes

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 3899-3909

  Louis Plence, Pascale ^a   Moreno, Carlos S ^a   Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; HIGH MOBILITY GROUP A1A PROTEIN; HIGH MOBILITY GROUP PROTEIN; MULTIPROTEIN COMPLEX; TRANSCRIPTION FACTOR; X BOX BINDING PROTEIN (RF X); X BOX BINDING PROTEIN (RF-X);

ARTICLE; BIOSYNTHESIS; BURKITT LYMPHOMA; CELL CULTURE; CHEMISTRY; DNA BASE COMPOSITION; GENE; GENETICS; HUMAN; IMMUNOLOGY; MACROMOLECULE; METABOLISM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN CONFORMATION; REGULATORY SEQUENCE; SEQUENCE ALIGNMENT; STEREOISOMERISM;

BASE COMPOSITION; BURKITT LYMPHOMA; CONSERVED SEQUENCE; DNA; DNA-BINDING PROTEINS; GENES, MHC CLASS II; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HUMANS; MACROMOLECULAR SUBSTANCES; MULTIPROTEIN COMPLEXES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN CONFORMATION; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE ALIGNMENT; STEREOISOMERISM; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031572574     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Saito, T., and R. N. Germain. 1988. The molecular basis of MHC-restricted antigen recognition by T cells. Int. Rev. Immunol. 3:147.
2. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class II transcription. In Annual Reviews of Immunology, 10th Ed. W. E. Paul, C. Garrison Fathman, and H. Metzger, eds. Annual Reviews, Inc., Palo Alto, p. 13.
3. Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681.
4. Griscelli, C., B. Lisowska-Grospierre, and B. Mach. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev. 1:135.
5. Benichou, B., and J. L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88: 4285.
6. Herrero-Sanchez, C., W. Reith, P. Silacci, and B. Mach. 1992. The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol. Cell. Biol. 12:4076.
7. Reith, W., V. Steimle, and B. Mach. 1995. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol. Today 16: 539.
8. Steimle, V., B. Durand, B. Emmanuele, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021.
9. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1045.
10. Kara, C. J., H. C. Liou, L. B. Ivashkiv, and L. H. Glimcher. 1990. A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol. Cell. Biol. 10:1347.
11. Andersson, G., and B. M. Peterlin. 1990. NF-X2 that binds to the DRA X2 box is activator protein 1: expression cloning of c-Jun. J. Immunol. 145:3456.
12. Liou, H.-C., M. R. Boothby, P. W. Finn, R. Davidon, N. Nabavi, N. J. Zeleznik-Le, J. P.-Y. Ting, and L. H. Glimcher. 1990. A new member of the leucine zipper class of proteins that binds to the HLA DRα promoter. Science 247:1581.
13. Hasegawa, S. L., and J. M. Boss. 1991. Two distinct B cell factors bind the HLA-DRA X box region and recognize different subsets of MHC class II promoters. Nucleic Acids Res. 19:6269.
14. Sinha, S., S. N. Maity, J. Lu, and B. De Crombrugghe. 1995. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc. Natl. Acad. Sci. USA 92:1624.
15. Zeleznik-Le, N. J., J. C. Azizkhan, and J. P.-Y Ting. 1991. Affinity-purified CCAAT box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873.
16. Vilen, B. J., J. P. Cogswell, and J. P.-Y. Ting. 1991. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function. Mol. Cell. Biol. 11:2406.
17. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709.
18. Kara, C. J., and L. H. Glimcher. 1993. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. J. Immunol. 150: 4934.
19. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
20. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313.
21. Kobr, M., W. Reith, C. Herrero-Sanchez, and B. Mach. 1990. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol. Cell. Biol. 10:965.
22. Emery, P., B. Mach, and W. Reith. 1993. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum. Immunol. 38:137.
23. Reith, W., M. Kobr, P. Emery, B. Durand, C.-A. Siegrist, and B. Mach. 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:20020.
24. Shapiro, D. J., P. A. Sharp, W. W. Wahli, and M. J. Keller. 1988. A high-efficiency HeLa cell nuclear transcription extract. DNA 7:47.
25. Moreno, C. S., E. M. Rogers, J. A. Brown, and J. M. Boss. 1997. RFX, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J. Immunol. 158:5841.
26. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, W. Strober, and R. Coico, eds. 1991. Current Protocols in Immunology. Vol. 1. John Wiley and Sons, New York.
27. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, Jr., J. L. Strominger, and J. S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917.
28. Paulnock King, D., K. C. Sizer, Y. R. Freund, P. P. Jones, and J. R. Parnes. 1985. Coordinate induction of Ia alpha, beta, and Ii mRNA in a macrophage cell line. J. Immunol. 135:632.
29. Boss, J. M., and J. L. Strominger. 1986. Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc. Natl. Acad. Sci. USA 83:9139.
30. Sherman, P. A., P. V. Basta, and J. P. Ting. 1987. Upstream DNA sequences required for tissue-specific expression of the HLA-DR alpha gene. Proc. Natl. Acad. Sci. USA 84:4254.
31. Sloan, J. H., and J. M. Boss. 1988. Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wildtype but not mutant B-cell lines. Proc. Natl. Acad. Sci. USA 85:8186.
32. Tsang, S. Y., M. Nakanishi, and B. M. Peterlin. 1990. Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol. Cell. Biol. 10:711.
33. Long, E. O., B. Mach, and R. S. Accolla. 1984. Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family. Immunogenetics 19:349.
34. de Preval, C., B. Lisowska-Grospierre, M. Loche, C. Griscelli, and B. Mach. 1985. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318:291.
35. Mach, B., V. Steimle, and W. Reith 1994. MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol. Rev. 138:207.
36. Chang, C.-H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
37. Kern, I., V. Steimle, C. Siegrist, and B. Mach. 1996. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes. Int. Immunol. 7:1295.
38. Westerheide, S. D., P. Louis-Plence, D. Ping, X.-F. He, and J. M. Boss. 1997. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J. Immunol. 158:4812.
39. Riley, J. L., and J. M. Boss. 1993. Class II MHC transcriptional mutants are defective in higher order complex formation. J. immunol. 151:6942.
40. Ronchi, A., M. Bellorini, N. Mongelli, and R. Mantovani. 1995. CCAAT box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA. Nucleic Acids Res. 23:4565.
41. Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitello, P. Cogswell, J. B. Clarke, and J. P.-Y. Ting. 1994. CCAAT box-binding protein, NF-Y, facilitates in vivo recruitment of upstream DNA-binding transcription factors. EMBO J. 13:4042.
42. Wright, K. L., and J. P.-Y. Ting. 1992. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma. Proc. Natl. Acad. Sci. USA 89:7601.
43. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
44. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.